LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.

Blood Adv · 2023 · PMC10410128 · PMID 37205853

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = .08so close (0.05 < p ≤ 0.1)

In a univariable Cox model, the impact of LSC17 status on OS was significant in patients with NPM1 -mutated AML (HR, 2.71; 95% CI, 1.63-4.53; P = .0001) but did not reach statistical significance in patients with AML with wild-type NPM1 (HR, 1.35; 95% CI, 0.96-1.89; P = .08; Figure 3 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.